A potential explanation for this distinction is that the increased ATOX1 expression in ER-positive tumors influences mitogen-activated protein kinase (MAPK) signaling, perhaps via the ATOX1–ATP7A–lysyl oxidase (LOX) axis [6], which in turn promotes tumor growth and metastasis. The gene discussed is WNK2; the disease is neoplasm.